Cargando…

Incidence and Characteristics of Patients with Visual Impairment due to Macular Edema Secondary to Retinal Vein Occlusion in a Representative Canadian Cohort

Retinal vein occlusion (RVO) is an obstruction of the retinal venous system, and macular edema (ME) is a complication of RVO that can lead to blindness. The Canadian incidence of visual impairment (VI) due to ME secondary to RVO is unknown. This observational, retrospective study used records from t...

Descripción completa

Detalles Bibliográficos
Autores principales: Petrella, Robert J., Blouin, Julie, Davies, Brian, Barbeau, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3477564/
https://www.ncbi.nlm.nih.gov/pubmed/23097691
http://dx.doi.org/10.1155/2012/723169
_version_ 1782247233049067520
author Petrella, Robert J.
Blouin, Julie
Davies, Brian
Barbeau, Martin
author_facet Petrella, Robert J.
Blouin, Julie
Davies, Brian
Barbeau, Martin
author_sort Petrella, Robert J.
collection PubMed
description Retinal vein occlusion (RVO) is an obstruction of the retinal venous system, and macular edema (ME) is a complication of RVO that can lead to blindness. The Canadian incidence of visual impairment (VI) due to ME secondary to RVO is unknown. This observational, retrospective study used records from the Southwestern Ontario database to observe the annual incidence, demographics, and comorbidity characteristics of patients with VI due to ME secondary to RVO. From 47,166 patients, 73 with RVO (>40 years old) were identified: 53 with branch retinal vein occlusion (BRVO), 20 with central retinal vein occlusion (CRVO). The annual incidence of VI (visual acuity <20/40 in Snellen equivalent) due to ME secondary to BRVO was (mean (95%CI)) 0.056% (0.011–0.072), and to CRVO was 0.021% (0.008–0.081). Furthermore, a greater proportion of RVO patients had hypertension (68% versus 14%) or dyslipidemia (16% versus 10%), when compared to a healthy control cohort of 76,077 subjects (P < 0.05). This study presents a description of the characteristics of patients with VI due to ME secondary to RVO in a real-world Canadian setting. The results demonstrate that BRVO was more frequent than CRVO, and that RVO in this patient population was associated with several vascular comorbidities.
format Online
Article
Text
id pubmed-3477564
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-34775642012-10-24 Incidence and Characteristics of Patients with Visual Impairment due to Macular Edema Secondary to Retinal Vein Occlusion in a Representative Canadian Cohort Petrella, Robert J. Blouin, Julie Davies, Brian Barbeau, Martin J Ophthalmol Clinical Study Retinal vein occlusion (RVO) is an obstruction of the retinal venous system, and macular edema (ME) is a complication of RVO that can lead to blindness. The Canadian incidence of visual impairment (VI) due to ME secondary to RVO is unknown. This observational, retrospective study used records from the Southwestern Ontario database to observe the annual incidence, demographics, and comorbidity characteristics of patients with VI due to ME secondary to RVO. From 47,166 patients, 73 with RVO (>40 years old) were identified: 53 with branch retinal vein occlusion (BRVO), 20 with central retinal vein occlusion (CRVO). The annual incidence of VI (visual acuity <20/40 in Snellen equivalent) due to ME secondary to BRVO was (mean (95%CI)) 0.056% (0.011–0.072), and to CRVO was 0.021% (0.008–0.081). Furthermore, a greater proportion of RVO patients had hypertension (68% versus 14%) or dyslipidemia (16% versus 10%), when compared to a healthy control cohort of 76,077 subjects (P < 0.05). This study presents a description of the characteristics of patients with VI due to ME secondary to RVO in a real-world Canadian setting. The results demonstrate that BRVO was more frequent than CRVO, and that RVO in this patient population was associated with several vascular comorbidities. Hindawi Publishing Corporation 2012 2012-10-14 /pmc/articles/PMC3477564/ /pubmed/23097691 http://dx.doi.org/10.1155/2012/723169 Text en Copyright © 2012 Robert J. Petrella et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Study
Petrella, Robert J.
Blouin, Julie
Davies, Brian
Barbeau, Martin
Incidence and Characteristics of Patients with Visual Impairment due to Macular Edema Secondary to Retinal Vein Occlusion in a Representative Canadian Cohort
title Incidence and Characteristics of Patients with Visual Impairment due to Macular Edema Secondary to Retinal Vein Occlusion in a Representative Canadian Cohort
title_full Incidence and Characteristics of Patients with Visual Impairment due to Macular Edema Secondary to Retinal Vein Occlusion in a Representative Canadian Cohort
title_fullStr Incidence and Characteristics of Patients with Visual Impairment due to Macular Edema Secondary to Retinal Vein Occlusion in a Representative Canadian Cohort
title_full_unstemmed Incidence and Characteristics of Patients with Visual Impairment due to Macular Edema Secondary to Retinal Vein Occlusion in a Representative Canadian Cohort
title_short Incidence and Characteristics of Patients with Visual Impairment due to Macular Edema Secondary to Retinal Vein Occlusion in a Representative Canadian Cohort
title_sort incidence and characteristics of patients with visual impairment due to macular edema secondary to retinal vein occlusion in a representative canadian cohort
topic Clinical Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3477564/
https://www.ncbi.nlm.nih.gov/pubmed/23097691
http://dx.doi.org/10.1155/2012/723169
work_keys_str_mv AT petrellarobertj incidenceandcharacteristicsofpatientswithvisualimpairmentduetomacularedemasecondarytoretinalveinocclusioninarepresentativecanadiancohort
AT blouinjulie incidenceandcharacteristicsofpatientswithvisualimpairmentduetomacularedemasecondarytoretinalveinocclusioninarepresentativecanadiancohort
AT daviesbrian incidenceandcharacteristicsofpatientswithvisualimpairmentduetomacularedemasecondarytoretinalveinocclusioninarepresentativecanadiancohort
AT barbeaumartin incidenceandcharacteristicsofpatientswithvisualimpairmentduetomacularedemasecondarytoretinalveinocclusioninarepresentativecanadiancohort